Jiri havranek - Latest News Update, Information, Photos & Videos on Jiri havranek at Lokmat Times

Glenmark Pharmaceuticals Limited, a research-led, global integrated pharmaceutical company today announced the launch of a bioequivalent version of Tiotropium Bromide dry powder inhaler (DPI) under the brand name Tavulus® in Spain, for the treatment of chronic obstructive pulmonary disease (COPD).COPD is a long-term condition that causes inflammation in the lungs, damaging the lung tissue and narrowing the airways, all of which make breathing difficult. Studies show that close to 2.5 million people suffer from COPD in Spain.[i]Tavulus® is expected to provide relief to a large patient population in the country. It is a long-acting bronchodilator that helps to open the airways and makes it easier for air to get in and out of the lungs. It also works to prevent sudden, short-term worsening of COPD symptoms.Commenting on the launch, Vice President - Business Development of Glenmark Pharmaceuticals Limited, Dr. Jiri Havranek, says, "The goal of COPD treatment has always been to provide quick symptomatic relief to patients, and reduce the risk of exacerbations. Since its launch, we have seen the multiple therapeutic benefits of Tavulus® in other markets, and we are pleased to extend these benefits to patients in Spain. This inhalation therapy has been shown to significantly aid in the daily management of COPD. We hope that it improves both COPD symptoms and quality of life in those who are most affected."In November 2017, a Glenmark European subsidiary entered into a strategic, exclusive in-licensing arrangement for marketing generic Tiotropium Bromide DPI in Western Europe and the UK. Glenmark is planning subsequent launches of the product across these markets under the brand name Tiogiva® in UK, Ireland, Sweden, Finland and Norway; Tavulus® in Denmark and Netherlands; and Tiotropium Glenmark® in Germany.This story is provided by PRNewswire. will not be responsible in any way for the content of this article. (/PRNewswire)( With inputs from ANI )Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Home

City

Latest News

Cricket

LT Premium

National

International

Maharashtra

Opinions

Chhatrapati Sambhajinagar

Nagpur

Entertainment

Photos

Business

Technology

Sports

Lifestyle

Social Viral

Lokmat Games

Health

Narendra Modi

Lok Sabha Election 2024

Heatwave In India

Mumbai Mega Block

Maharashtra Lok Sabha Election

T20 World Cup 2024

Jiri HavranekFOLLOW

Jiri havranek, Latest News

Business :Glenmark launches Tavulus® for COPD treatment in Spain

Glenmark Pharmaceuticals Limited, a research-led, global integrated pharmaceutical company today announced the launch of a bioequivalent version of Tiotropium Bromide dry powder inhaler (DPI) under the brand name Tavulus® in Spain, for the treatment ...